Drug and Alcohol Review (via Wiley), Melbourne, 2022. 4p.
Level of hesitancy in this group warrants a targeted strategy to mitigate concerns and maximise uptake. Ideally, this should comprise an inclusive health response that is peer-led, with peer-based organisations.
National Drug & Alcohol Research Centre (NDARC), Sydney, 2022.
Looks at 3 key reasons why people who inject drugs should be encouraged to be vaccinated and reports on a survey of injecting drug user’s attitudes towards vaccine intentions and attitudes.
Nature Scientific Reports, London, 2022.
The successful use of DBS has the potential to expand access to HCV testing to underserved or marginalized populations: this study evaluated the use of DBS whole blood samples.
Int Network on Hepatitis in Substance Users (INHSU), Zurich, 2021. 58:06 video
Key notes (and video) from a virtual satellite session at the INHSU 2021 conference, entitled ‘Hepatitis C self-testing: empowering people who use drugs and increasing access to HCV testing and care’.
Medical News Today, Bexhill-on-Sea, 2022. 7p.
Information about average incubation periods, detection, transmission, symptoms, testing and treatment.
AFAO & Anwernekenhe National HIV Alliance, Sydney, 2022. Website.
Sexual health resource for Aboriginal and Torres Strait Islander people: info about common STIs, what to do and where to get tested. Contains info about both men's and women's business.
Hep C Trust & HCV Action, London, 2022. 20p.
Reports what NHS and frontline are seeing in relation to reinfection, what is already being done, and what more could be put in place to address this.
Medical News Today, Bexhill-on-Sea, 2022.
What it means to be a carrier (asymptomatic or otherwise); who is likely to be a carrier and how it may be transmitted; how it may affect a person; how to prevent the spread; diagnosis, and treatment.
Harm Reduction Journal (via Springer Nature) , London, 2022. 21p
The development of trusting relationships with non-judgemental staff can facilitate service engagement. Peer-delivered approaches show particular promise, but evidence is still developing.
NDARC & AIVL, Sydney, 2022. 7p.
-And what info do they receive prior? Progression from 1st to regular injecting is typically rapid: the way in which a person starts injecting is likely to influence future practices and risk- taking.
UNSW Community, Sydney, 2022. Video 1 1/2 hrs
Peer-led program offering education and screening for hep B,C and STIs for Aboriginal people. Hear from Aboriginal workers and get a preview of the online DLM program toolkit.
Infohep, London, 2022. 2p.
The study reports that hepatitis C is associated with cognitive impairment and clearing hepatitis C results in improved cognitive functioning and reduction in depression and anxiety.
Hepatitis Queensland, Brisbane, 2022. Webpage
Contains useful lifestyle information about healthy diet, alcohol consumption, exercise, hepatitis testing and health check. Contains links to more info about health goals and liver health.
Clinical Gastroenterology and Hepatology via Elsevier. Amsterdam. 1p. detailed abstract.
This study aimed to examine the impact of coffee consumption with liver fibrosis and steatosis in a nationally representative sample.
The Lancet Gastroenterology and Hepatology (via Elsevier), London, 2022. 2p.
An interdisciplinary group gathered evidence and set out a framework for action for HBV, considering the challenges and barriers to engagement, and reflecting on the need for patient voices. Access with login (free).
BMC Systematic Reviews, London, 2022. 11p.
An in-depth understanding of the stigma associated with mental health conditions and AOD use among people from migrant and ethnic minority backgrounds. The findings will inform culturally responsive interventions.
Australian Indigenous HealthInfoNet, Perth, 2022. 110p.Information about the context of Aboriginal and Torres Strait Islander health, population, and measures of population health status. Contains selected health conditions, risk and protective factors.
Viruses (via MDPI), Basel Swi, 2022. 15p.
The scale-up of hep C prevention, testing, and treatment programs in prisons is critical to achieving WHO elimination goals. Discusses opportunities to improve access to prevention, testing, and treatment.
Healio, Thorofare NJ, 2022. 2p. article review
The findings of the SToP-C study showed the need for regular post-treatment surveillance and access to harm reduction services, including improved opioid agonist therapy c and needle and syringe programs.
GEAS, ASID, Hepatitis Australia, Canberra, 2021. 20p.
Commentary has been provided to provide additional clarification or detail variations found in the Australian setting. Topics include testing, transmission, prevention, medical management and treatment.See also Decision making - hepatitis C in children.
Lancet Public Health (via Elsevier), London, 2022. 4p. (open access)
Argues that global elimination and treatment efforts will continue to fail until structural factors, such as housing, that influence the basic survival of people at risk, particularly PWID, are included.
UK Health Security Agency, London, 2022. 135p.
Summarises the scale of infection and related disease and presents data to identify where focused action is needed to eliminate HCV as a major public health problem by 2030.
Medical Journal of Australia, Sydney, 2022. 9p.
Developed by the Gastroenterological Society of Australia (GESA) to provide a list of contemporary recommendations for health professionals involved in the care of patients living with hep B infection.
The Kirby Institute, Sydney, 2021. 16p.
Reports on the 14 targets of the strategy with statistics relating to outcomes and recommendations for future action.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.